Satsuma Pharmaceuticals, Inc. announced that Immediately following the Effective Time Tom O'Neil ceased serving as Chief Financial Officer of the Company.
Satsuma Pharmaceuticals, Inc.
Equities
STSA
US80405P1075
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.11% | 114B | |
+11.46% | 104B | |
-13.88% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.73% | 17.89B | |
+7.85% | 14.28B | |
+34.82% | 12.55B |